Fundraising Fox株式会社iXgene
Tokyo, JP · 2 known investors
Find your way into 株式会社iXgene
Sign up to see every warm intro you have to 株式会社iXgene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社iXgene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
iXgene develops regenerative medicine therapies using genome-edited induced pluripotent stem cells (iPSCs) to treat conditions including glioblastoma and traumatic brain injury. The company focuses on gene and cell therapies derived from genetically engineered stem cells.
Founders & leadership
TF
Toshiharu Furukawa
AM
Atsushi MizunoAtsushi Mizuno is co-founder and COO of iXgene, a regenerative medicine company developing iPSC-based therapies for brain conditions. He holds a PhD in Biotechnology and has experience in life science startups and university technology commercialization.
Investors · 2
Frequently asked questions
- What does 株式会社iXgene do?
- iXgene develops regenerative medicine therapies using genome-edited induced pluripotent stem cells (iPSCs) to treat conditions including glioblastoma and traumatic brain injury. The company focuses on gene and cell therapies derived from genetically engineered stem cells.
- Who founded 株式会社iXgene?
- 株式会社iXgene was founded by Toshiharu Furukawa, Atsushi Mizuno.
- Who are 株式会社iXgene's investors?
- 株式会社iXgene's investors include Keio Innovation Initiative, UTokyo Innovation Platform Co. Ltd..
- Where is 株式会社iXgene headquartered?
- 株式会社iXgene is headquartered in Tokyo, JP.